Amundi Novavax Inc Transaction History

Amundi

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $29,805 - $84,234	3,364 Added 133.28%	5,888 $60,000
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $1.06 Million - $2.2 Million	-29,250 Reduced 92.06%	2,524 $130,000
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $2,580 - $5,287	-37 Reduced 0.12%	31,774 $1.89 Million
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $217,448 - $352,239	-1,616 Reduced 4.83%	31,811 $3.57 Million
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $1.11 Million - $1.68 Million	6,221 Added 22.87%	33,427 $6.93 Million
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $3.29 Million - $7.01 Million	27,206 New	27,206 $5.78 Million

286

84.7M

5.38M

8.62M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $718M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

Stay updated on Amundi with notifications on news.